Studying the cardiometabolic impact of testosterone therapies on transgender boys and men to advance their health and wellbeing
Return to Listing
Transgender individuals are those with a gender identity opposite the sex they were assigned at birth. Approximately 1% of the population is transgender, equating to approximately 60,000 Wisconsinites who identify as transgender.
Transgender boys and men may wish to pursue gender-affirming medical and surgical interventions so their body better aligns with their gender identity. Any medical or surgical interventions require that the patient truly understand all the risks and benefits, and shares in the decision-making process. Currently the knowledge of risks and benefits for gender-affirming care of transgender boys and men are based on limited studies, and not much is known about the impact of testosterone therapies on cardiovascular and metabolic diseases.
Through this award, investigators will implement a first-of-its-kind longitudinal study of the cardiometabolic impact of testosterone in transgender boys and trans men in order to offer critical information for care providers and patients to optimize their health and wellbeing.
8701 W Watertown Plank Road,
Milwaukee, WI 53226-0509
Governance and Reporting
Maps & Directions
©2021 MEDICAL COLLEGE OF WISCONSIN. ALL RIGHTS RESERVED | MCW.EDU | TERMS & PRIVACY | NON-DISCRIMINATION NOTICE